FDA Approved: XIIDRA — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Xiidra (lifitegrast) submitted by Novartis Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Xiidra (Lifitegrast)

Snippet

SUPPL AP for XIIDRA (LIFITEGRAST)